Genotype-directed Neoadjuvant Chemoradiation for Rectal Carcinoma

NCT00682786 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

135

Enrollment

OTHER

Sponsor class

Conditions

Rectal Carcinoma

Interventions

DRUG: 5FU
RADIATION: Radiation
PROCEDURE: Surgery of resectable lesions
DRUG: Irinotecan

Sponsor

Washington University School of Medicine